SCHEMBL31332000

CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	NMUR2	Q9GZQ4	5/20	0.61

▸	NMUR1	Q9HB89	4/20	0.61

▸	F2	P00734	4/20	0.60

▸	OPRM1	P35372	1/20	0.58

▸	OPRD1	P41143	1/20	0.58

▸	NPY2R	P49146	5/20	0.56

▸	NPY4R	P50391	5/20	0.56

▸	NPY5R	Q15761	5/20	0.56

▸	NPY1R	P25929	4/20	0.56

▸	CXCL8	P10145	3/20	0.56

▸	KEAP1	Q14145	1/20	0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30017187	0.94	NPY2R (0.64)	F2OPRM1OPRD1NPY2RNPY4R
SCHEMBL29681572	0.93	OPRM1 (0.59)	NMUR2NMUR1F2OPRM1OPRD1
SCHEMBL29755299	0.91	KEAP1 (0.58)	NMUR2NMUR1F2OPRM1OPRD1
SCHEMBL29746818	0.87	NMUR2 (0.52)	NMUR2NMUR1OPRM1OPRD1NPY2R
SCHEMBL30974100	0.87	TFPI (0.66)	NMUR2NMUR1OPRM1OPRD1NPY2R
SCHEMBL30930530	0.87	NPY2R (0.54)	NMUR2NMUR1OPRM1OPRD1NPY2R
SCHEMBL31182741	0.87	CALCR (0.62)	NMUR2NMUR1F2NPY2RNPY4R
SCHEMBL30111330	0.87	KDM1A (0.66)	F2NPY2RNPY4RNPY5RNPY1R
SCHEMBL31005066	0.86	TFPI (0.66)	NMUR2NMUR1NPY2RNPY4RNPY5R
SCHEMBL29654647	0.86	KEAP1 (0.55)	NMUR2NMUR1F2OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	LONGEVITY BIOTECH, INC.	2024-11-14	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20240374689-A1	HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME	SCTR, GIPR, APLNR	NMUR2 664/4885NMUR1 461/4885F2 3164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.